Read more

June 04, 2020
1 min read
Save

Melanoma Research Foundation presents Humanitarian Award

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Melanoma Research Foundation will present its Humanitarian Award to Andrew E. Aplin, PhD.

The award recognizes a leader in the melanoma community who is dedicated to exemplary patient care, scientific leadership or cutting-edge research.

Aplin is Kalbach-Newton professor in cancer research, enterprise associate director for basic research, and program leader for cancer cell biology and signaling at Sidney Kimmel Cancer Center — Jefferson Health.

Andrew E. Aplin, PhD
Andrew E. Aplin

“I am honored that the Melanoma Research Foundation is recognizing our research team with a Humanitarian Award,” Aplin said in a press release. “We are excited to increase wet lab-based activities that were deescalated during COVID-19 and this grant from the Melanoma Research Foundation will make that possible.”

Aplin’s research focuses on improving the understanding of the mechanisms that cause aberrant cell growth and invasion in subsets of melanoma, as well identifying novel therapeutic targets. His laboratory is studying modes of resistance to RAF inhibitors. He also conducts research related to uveal melanoma.